These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

26 related articles for article (PubMed ID: 7805226)

  • 1. Action potential responses to changes in stimulation frequency and isoproterenol in rat ventricular myocytes.
    Howlett LA; Kirton HM; Al-Owais MM; Steele D; Lancaster MK
    Physiol Rep; 2022 Jan; 10(2):e15166. PubMed ID: 35076184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular determinants of pro-arrhythmia proclivity of d- and l-sotalol via a multi-scale modeling pipeline.
    DeMarco KR; Yang PC; Singh V; Furutani K; Dawson JRD; Jeng MT; Fettinger JC; Bekker S; Ngo VA; Noskov SY; Yarov-Yarovoy V; Sack JT; Wulff H; Clancy CE; Vorobyov I
    J Mol Cell Cardiol; 2021 Sep; 158():163-177. PubMed ID: 34062207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacological properties of K+ currents from rabbit isolated aortic smooth muscle cells.
    Halliday FC; Aaronson PI; Evans AM; Gurney AM
    Br J Pharmacol; 1995 Dec; 116(8):3139-48. PubMed ID: 8719788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamic, pharmacokinetic and antiarrhythmic properties of d-sotalol, the dextro-isomer of sotalol.
    Advani SV; Singh BN
    Drugs; 1995 May; 49(5):664-79. PubMed ID: 7601009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of d, l-sotalol and d-sotalol on isoproterenol-increased delayed rectifier outward potassium current in guinea pig single ventricular myocytes.
    Yao X; Yannoulis NC; Kiehn J; Lu Z; Zhao H; Brachmann J
    J Tongji Med Univ; 1998; 18(1):13-7. PubMed ID: 10806794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of the new class III antiarrhythmic agents almokalant, E-4031 and D-sotalol, and of quinidine, on delayed rectifier currents in guinea pig ventricular myocytes.
    Wettwer E; Grundke M; Ravens U
    Cardiovasc Res; 1992 Nov; 26(11):1145-52. PubMed ID: 1291093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential class III and glibenclamide effects on action potential duration in guinea-pig papillary muscle during normoxia and hypoxia/ischaemia.
    MacKenzie I; Saville VL; Waterfall JF
    Br J Pharmacol; 1993 Oct; 110(2):531-8. PubMed ID: 8242227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sympathetic activation, ventricular repolarization and Ikr blockade: implications for the antifibrillatory efficacy of potassium channel blocking agents.
    Vanoli E; Priori SG; Nakagawa H; Hirao K; Napolitano C; Diehl L; Lazzara R; Schwartz PJ
    J Am Coll Cardiol; 1995 Jun; 25(7):1609-14. PubMed ID: 7759713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrophysiological effects of MS-551, a new class III agent: comparison with dl-sotalol in dogs.
    Sen L; Cui G; Sakaguchi Y; Singh BN
    J Pharmacol Exp Ther; 1998 May; 285(2):687-94. PubMed ID: 9580614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-adrenergic blocking property of dl-sotalol maintains class III efficacy in guinea pig ventricular muscle after isoproterenol.
    Groh WJ; Gibson KJ; McAnulty JH; Maylie JG
    Circulation; 1995 Jan; 91(2):262-4. PubMed ID: 7805226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacologic basis of the antiarrhythmic and hemodynamic effects of sotalol.
    Antonaccio MJ; Gomoll A
    Am J Cardiol; 1993 Aug; 72(4):27A-37A. PubMed ID: 8346723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrophysiologic properties of sotalol and d-sotalol. A current view.
    Touboul P
    Eur Heart J; 1993 Nov; 14 Suppl H():24-9. PubMed ID: 7904935
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.